BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35183359)

  • 21. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
    Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
    World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and Technical Guideline for Endoscopic Ultrasound-guided Tissue Acquisition of Pancreatic Solid Tumor: Korean Society of Gastrointestinal Endoscopy].
    Chung MJ; Park SW; Kim SH; Cho CM; Choi JH; Choi EK; Lee TH; Cho E; Lee JK; Song TJ; Lee JM; Son JH; Park JS; Oh CH; Park DA; Byeon JS; Lee ST; Kim HG; Chun HJ; Choi HS; Park CG; Cho JY
    Korean J Gastroenterol; 2021 Aug; 78(2):73-93. PubMed ID: 34446631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early detection and prevention of pancreatic cancer: is it really possible today?
    Del Chiaro M; Segersvärd R; Lohr M; Verbeke C
    World J Gastroenterol; 2014 Sep; 20(34):12118-31. PubMed ID: 25232247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Consortium.
    Gonda TA; Everett JN; Wallace M; Simeone DM;
    Gastroenterology; 2021 Dec; 161(6):1751-1757. PubMed ID: 34454916
    [No Abstract]   [Full Text] [Related]  

  • 25. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Approaches to Pancreatic Cancer Screening.
    Chhoda A; Lu L; Clerkin BM; Risch H; Farrell JJ
    Am J Pathol; 2019 Jan; 189(1):22-35. PubMed ID: 30558719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention.
    Hart SL; Torbit LA; Crangle CJ; Esplen MJ; Holter S; Semotiuk K; Borgida A; Ardiles P; Rothenmund H; Gallinger S
    Psychooncology; 2012 Dec; 21(12):1324-30. PubMed ID: 21774034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for pancreatic adenocarcinoma: are we ready for screening and surveillance?
    Brand R; Mahr C
    Curr Gastroenterol Rep; 2005 May; 7(2):122-7. PubMed ID: 15802100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.
    Young MR; Wagner PD; Ghosh S; Rinaudo JA; Baker SG; Zaret KS; Goggins M; Srivastava S
    Pancreas; 2018 Feb; 47(2):135-141. PubMed ID: 29346214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning.
    Maheu C; Vodermaier A; Rothenmund H; Gallinger S; Ardiles P; Semotiuk K; Holter S; Thayalan S; Esplen MJ
    Fam Cancer; 2010 Dec; 9(4):617-24. PubMed ID: 20623197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance.
    Abe T; Blackford AL; Tamura K; Ford M; McCormick P; Chuidian M; Almario JA; Borges M; Lennon AM; Shin EJ; Klein AP; Hruban RH; Canto MI; Goggins M
    J Clin Oncol; 2019 May; 37(13):1070-1080. PubMed ID: 30883245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.
    Lucas AL; Frado LE; Hwang C; Kumar S; Khanna LG; Levinson EJ; Chabot JA; Chung WK; Frucht H
    Cancer; 2014 Jul; 120(13):1960-7. PubMed ID: 24737347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers.
    Fukushige S; Horii A
    Cancer Lett; 2014 Jan; 342(2):231-7. PubMed ID: 22450751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
    Goggins M; Overbeek KA; Brand R; Syngal S; Del Chiaro M; Bartsch DK; Bassi C; Carrato A; Farrell J; Fishman EK; Fockens P; Gress TM; van Hooft JE; Hruban RH; Kastrinos F; Klein A; Lennon AM; Lucas A; Park W; Rustgi A; Simeone D; Stoffel E; Vasen HFA; Cahen DL; Canto MI; Bruno M;
    Gut; 2020 Jan; 69(1):7-17. PubMed ID: 31672839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early detection of pancreatic cancer: Where are we now and where are we going?
    Zhou B; Xu JW; Cheng YG; Gao JY; Hu SY; Wang L; Zhan HX
    Int J Cancer; 2017 Jul; 141(2):231-241. PubMed ID: 28240774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: methodology and review of evidence.
    ; Buxbaum JL; Freeman M; Amateau SK; Chalhoub JM; Chowdhury A; Coelho-Prabhu N; Das R; Desai M; Elhanafi SE; Forbes N; Fujii-Lau LL; Kohli DR; Kwon RS; Machicado JD; Marya NB; Pawa S; Ruan WH; Sadik J; Sheth SG; Thiruvengadam NR; Thosani NC; Zhou S; Qumseya BJ;
    Gastrointest Endosc; 2023 Feb; 97(2):163-183.e40. PubMed ID: 36517309
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic testing by cancer site: pancreas.
    Axilbund JE; Wiley EA
    Cancer J; 2012; 18(4):350-4. PubMed ID: 22846737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
    Canto MI; Harinck F; Hruban RH; Offerhaus GJ; Poley JW; Kamel I; Nio Y; Schulick RS; Bassi C; Kluijt I; Levy MJ; Chak A; Fockens P; Goggins M; Bruno M;
    Gut; 2013 Mar; 62(3):339-47. PubMed ID: 23135763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening.
    Bruenderman EH; Martin RC
    J Surg Res; 2015 Mar; 194(1):212-9. PubMed ID: 25479908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial gastric and pancreatic cancers: Diagnosis and screening.
    Raymond VM; Stoffel EM
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.